This article in Healing Innovation caught our eyes.   According to the article, unlike most of the world whose regulatory bodies approve medical devices based on safety, the FDA approves medical devices based on both safety and effectiveness.  Evaluating the effectiveness of an investigational product is what is largely responsible for the length of clinical trials that delay approval of novel medical devices.